End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.69 USD | +5.87% | +13.20% | -38.93% |
Apr. 03 | Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing | MT |
Mar. 26 | Gyre Therapeutics Swings to Fiscal 2023 Net Loss, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-38.93% | 1.34B | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- GYRE Stock
- News Gyre Therapeutics, Inc.
- Gyre Therapeutics Swings to Fiscal 2023 Net Loss, Revenue Rises